ALS-associated mutations may inhibit DnaJC7 interaction with other chaperones (i.e., Hsp70 and Hsp90) and thus impair substrate (tau) handoff into the chaperone-mediated protein refolding cycle. Here, MAPT is linked to amyotrophic lateral sclerosis.